Toptal Blog

The attention on international payments tends to center around innovations appearing in the developed world. But what about developing countries?

This article addresses what contributes to volatility and illiquidity in emerging market currencies, and how they can stabilize to become more flexible.

Elm is a purely functional, strongly typed, reactive, and event-driven web client language. It takes a step back from the norms and really changes the way you reason about and program web application front-ends.

In this article, Toptal Freelance Software Engineer Vuk Djapic takes you through the exotic concepts of Elm and its pros and cons in real world use.

New fintech apps are changing how we see our investment goals and interact with financial institutions. This article reviews best practices for building trust without sacrificing fun or usability.

Microinteractions are single interactive moments in a product that enhance the workflow and make a product more enjoyable. This article highlights key parts of microinteractions and patterns.

The fitness industry is large, growing steadily and rapidly evolving. Since the 1980s, health club locations and memberships have more than tripled to 36,000 and 57 million, respectively. Yet, over the past decade, 35% of its customer base has shifted away from incumbent brands.

This article analyzes some of the shifts in the fitness industry that are illustrative of broader economic issues and highlights interesting implications for other consumer-facing businesses.

You might have heard about the new kid around the block: GraphQL. If not, GraphQL is, in a word, a new way to fetch APIs, an alternative to REST.

What is DevOps, and why is it important for your organization to understand and implement? Alvaro Oliveira, VP of Talent Operations at Toptal, provides a comprehensive, non-technical explanation of what DevOps means, and explores why DevOps principles are crucial for enterprise organizations of all stripes to consider.

Pharma R&D is a notoriously long and arduous process, and it can take more than 10 years and $2.6 billion to bring a single drug to market. Among the biggest players, the return on investment for R&D fell to 3.7% in 2016. However, a solution could be data analytics, which enhances and accelerates drug development.

This article examines the current state of drug development, and how big data can improve its different components: drug discovery, clinical trial design, and adverse drug reaction detection.

What makes software developers tick? With this theme in mind, we will present some ways to retain employees that we have identified in successful software development teams.